Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04212013
Title A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

marginal zone B-cell lymphoma

Therapies

Ibrutinib

Ibrutinib + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.